Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
| Status: | Completed |
|---|---|
| Conditions: | Back Pain, Back Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 12/14/2018 |
| Start Date: | September 7, 2017 |
| End Date: | January 10, 2018 |
Effect of Transcranial Alternating Current Stimulation in Chronic Low Back Pain: A Pilot Study
Chronic pain is a severe disabling problem within society, affecting 25-30% of the United
States population.. Transcranial alternating current stimulation (tACS) has the potential to
provide a treatment option that is safe, scientifically-supported, low-cost, and
easy-to-administer method to effectively reduce symptoms in patients suffering from chronic
pain. The purpose of this study is to test the feasibility of using tACS to treat patients
with chronic pain, and to collect pilot efficacy as well as EEG and EKG biomarker data for
optimizing the design of subsequent large-scale studies. The treatment rationale is to
renormalize the presumed pathological structure of alpha oscillations in the prefrontal
cortex (PFC) of patients with chronic pain.
States population.. Transcranial alternating current stimulation (tACS) has the potential to
provide a treatment option that is safe, scientifically-supported, low-cost, and
easy-to-administer method to effectively reduce symptoms in patients suffering from chronic
pain. The purpose of this study is to test the feasibility of using tACS to treat patients
with chronic pain, and to collect pilot efficacy as well as EEG and EKG biomarker data for
optimizing the design of subsequent large-scale studies. The treatment rationale is to
renormalize the presumed pathological structure of alpha oscillations in the prefrontal
cortex (PFC) of patients with chronic pain.
Inclusion Criteria:
- Male or female, aged 18-65
- Diagnosed with nonspecific chronic low back pain by clinician
- BMI is less than 30
- Suffered from chronic pain for > 6 months
- Self-report pain measures >4
- Meets criteria for low depression and suicide risk as defined by the
Hamilton-Depression Rating Scale
- Capacity to understand all relevant risks and potential benefits of the study
(informed consent)
- Not currently taking opioids, benzodiazepines, and anticonvulsant medications
Exclusion Criteria:
- Radicular Pain
- Traumatic brain injury, Any brain devices/implants, including cochlear implants and
aneurysm clips
- History of major neurological or psychiatric illness, including epilepsy
- (For females) Pregnancy or breast feeding
- Diagnosis of eating disorder (current or within the past 6 months), Obsessive
Compulsive Disorder (lifetime), or Attention-Deficit Hyperactivity Disorder (currently
under treatment)
We found this trial at
1
site
Chapel Hill, North Carolina 27599
(919) 962-2211
Principal Investigator: Karen McCulloch, PhD, DPT
Phone: 919-962-5271
University of North Carolina at Chapel Hill Carolina’s vibrant people and programs attest to the...
Click here to add this to my saved trials
